A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Ep0085 905, Beijing

Ep0085 901, Chengdu

Ep0085 902, Guangzhou

Ep0085 909, Guangzhou

Ep0085 917, Guangzhou

Ep0085 920, Guangzhou

Ep0085 924, Guangzhou

Ep0085 912, Hangzhou

Ep0085 908, Lanzhou

Ep0085 921, Nanchang

Ep0085 926, Pingxiang

Ep0085 910, Shijiazhuang

Ep0085 925, Suzhou

Ep0085 913, Wenzhou

Ep0085 930, Xinxiang

Ep0085 916, Yinchuan

Ep0085 918, Zhanjiang

Ep0085 904, Zhengzhou

Ep0085 923, Zunyi

Ep0085 148, Adachi-ku

Ep0085 116, Asaka

Ep0085 126, Bunkyō City

Ep0085 127, Bunkyō City

Ep0085 122, Hachinohe

Ep0085 111, Hamamatsu

Ep0085 141, Higashisonogi-gun Kawatana-cho

Ep0085 110, Hiroshima

Ep0085 121, Itami

Ep0085 102, Kagoshima

Ep0085 142, Kamakura

Ep0085 140, Kawasaki

Ep0085 123, Kodaira

Ep0085 115, Kokubunji

Ep0085 132, Kōriyama

Ep0085 112, Kōshi

Ep0085 128, Kurume

Ep0085 124, Kyoto

Ep0085 147, Kyoto

Ep0085 105, Nagakute

Ep0085 118, Nagoya

Ep0085 136, Nagoya

Ep0085 117, Nara

Ep0085 129, Neyagawa

Ep0085 106, Niigata

Ep0085 850, Osaka

Ep0085 130, Ôsaka

Ep0085 131, Ōtsu

Ep0085 114, Saitama

Ep0085 101, Sapporo

Ep0085 103, Sendai

Ep0085 144, Shinjuku-ku

Ep0085 104, Shizuoka

Ep0085 108, Suita

Ep0085 137, Suita

Ep0085 138, Tsukuba

Ep0085 133, Ushiku

Ep0085 109, Yamagata

Ep0085 120, Yokohama

Ep0085 150, Yokohama